MA45752B2 - Steroids and their protein conjugates - Google Patents

Steroids and their protein conjugates

Info

Publication number
MA45752B2
MA45752B2 MA45752A MA45752A MA45752B2 MA 45752 B2 MA45752 B2 MA 45752B2 MA 45752 A MA45752 A MA 45752A MA 45752 A MA45752 A MA 45752A MA 45752 B2 MA45752 B2 MA 45752B2
Authority
MA
Morocco
Prior art keywords
steroids
protein conjugates
protein
conjugates
glucocorticoids
Prior art date
Application number
MA45752A
Other languages
French (fr)
Other versions
MA45752A1 (en
Inventor
William Olson
Amy Han
J Andrew Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2017/060434 external-priority patent/WO2018089373A2/en
Publication of MA45752A1 publication Critical patent/MA45752A1/en
Publication of MA45752B2 publication Critical patent/MA45752B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des conjugués de stéroïdes protéiques qui sont utiles, par exemple, pour l'administration spécifique à une cible de glucocorticoïdes (gc) à des cellules.Disclosed herein are protein steroid conjugates which are useful, for example, for the target-specific delivery of glucocorticoids (gc) to cells.

MA45752A 2016-11-08 2017-11-07 Steroids and their protein conjugates MA45752B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662419365P 2016-11-08 2016-11-08
PCT/US2017/060434 WO2018089373A2 (en) 2016-11-08 2017-11-07 Steroids and protein-conjugates thereof

Publications (2)

Publication Number Publication Date
MA45752A1 MA45752A1 (en) 2020-06-30
MA45752B2 true MA45752B2 (en) 2022-12-30

Family

ID=72291376

Family Applications (4)

Application Number Title Priority Date Filing Date
MA51971A MA51971B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES
MA51969A MA51969B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES
MA45752A MA45752B2 (en) 2016-11-08 2017-11-07 Steroids and their protein conjugates
MA51970A MA51970B1 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MA51971A MA51971B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES
MA51969A MA51969B2 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA51970A MA51970B1 (en) 2016-11-08 2017-11-07 STEROIDS AND THEIR PROTEIN CONJUGATES

Country Status (2)

Country Link
CL (1) CL2023000971A1 (en)
MA (4) MA51971B2 (en)

Also Published As

Publication number Publication date
MA51971A1 (en) 2022-06-30
MA51969A1 (en) 2022-08-31
MA51971B2 (en) 2024-05-31
MA45752A1 (en) 2020-06-30
MA51970B1 (en) 2023-11-30
CL2023000971A1 (en) 2023-09-29
MA51970A1 (en) 2022-08-31
MA51969B2 (en) 2024-05-31

Similar Documents

Publication Publication Date Title
MA50259A1 (en) Steroids and their antibody conjugates
MA45029B1 (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
MX2023014120A (en) Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods.
MD3804737T2 (en) Compositions comprising bacterial strains
MX2020001270A (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies.
MX2023011657A (en) Compositions comprising curons and uses thereof.
MA41937B1 (en) DRUG CONJUGATES INCLUDING CLAUDINE ANTIBODIES 18.2
MX2021000965A (en) Compositions comprising circular polyribonucleotides and uses thereof.
BR112018016450A2 (en) vcn enhancer compositions and methods of using them
MA40662B1 (en) Antibodies against tigit
MA40132A1 (en) Macrocyclic Inhibitors of Protein / protein Interactions pd-1 / pd-11 and cd80 (b7-1) / pd-li
MA47392A1 (en) Bis-octahydrophenanthrene carboxamides and their protein conjugates
CY1124704T1 (en) SOBETIROME PRODUCT
CL2019002251A1 (en) Antibodies against tryptase, compositions of these and uses of these.
BR112021016056A2 (en) Claudin 6 antibodies and their uses
BR112018009004A8 (en) anti-cd3-folate conjugates and their uses
MX2020013389A (en) Terlipressin compositions and uses thereof.
UY37800A (en) IRNA AGENTS FOR THE INHIBITION OF ALFA-ENaC EXPRESSION AND METHODS OF USE
MX2020011027A (en) Trivalent trispecific antibody constructs.
WO2019036725A3 (en) Tau aggregation peptide inhibitors
MA51969A1 (en) Steroids and their protein conjugates
MX2021006941A (en) Anellosomes for delivering intracellular therapeutic modalities.
EA201900275A1 (en) STEROIDS AND THEIR PROTEIN CONJUGATES
MA51297B1 (en) Quinazolinones as parp14 inhibitors
EA202090234A1 (en) RNAi MEANS FOR INHIBITING ALPHA-ENaC EXPRESSION AND METHODS OF APPLICATION